Penn Medicine researchers found that removing race from a kidney function algorithm led to reduced chemotherapy access and lower Black patient eligibility in clinical trials.
Penn Medicine researchers found that removing race from a kidney function algorithm, which was intended to reduce racial inequity, also led to reduced chemotherapy access, lower Black patient eligibility in clinical trials, and affected medication dosing. The issue of race and ethnicity in health care algorithms is complicated, with consequences that extend beyond the original intent.
March 25, 2024
4 Articles